J-Pharma Co Ltd is engaged in the Drug discovery and development targeting SLC transporters. J-Pharma (TKS: 520A) is based in Tokyo, Japan and was founded in 2005. It is now publicly traded; this page covers its private-market history, where its last recorded valuation was $99.4 million (Mar 2026). It has raised $83.1 million.
Last price · $/share
—
Implied valuation
$99.4M
Total raised
$83.1M
Last round
—
Cap table — not yet on record
J-Pharma (TKS: 520A)'s share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of J-Pharma (TKS: 520A) with a free account
·The complete investor list: 30 names
·Watch J-Pharma (TKS: 520A): the Monday email on marks, rounds and moves
